
Case Study: How Patient Preference Data Rescued a High-Risk Device
From Let's Talk Risk! with Dr. Naveen Agarwal by Casual and informal conversations about practical aspects of medical device risk management.
April 10, 2026 · 21 min
About this episode
This episode discusses how patient preference data can influence the approval of high-risk medical devices despite serious adverse events.
Imagine you are running a pivotal clinical trial for a novel implant. The data comes back, and it is rough: 80% of your patients have suffered a serious adverse event, and 40% have developed acute kidney injury. If you are sitting in the regulatory or risk management seat, you are likely drafting the project’s post-mortem. In a traditional risk management paradigm, you are preparing to tell the executive team that the device failed to meet any traditional safety threshold. But what if the FDA didn’t just approve this device, but approved it specifically because the sponsors mathematically proved that patients were willing to tolerate a higher level or risk to gain access to this device? This scenario completely dismantles the way the MedTech industry has historically viewed safety and effectiveness. As professionals, we are trained to treat clinical thresholds as objective, immutable laws of physics—a line in the sand where an adverse event rate either passes or fails. However, with the FDA’s finalized guidance issued on March 30, 2026, safety is no longer just a raw numerical threshold; it is now a quantifiable variable relative to the validated preference of the end user. So…
People in this episode
Host: Dr. Naveen Agarwal
Topics covered
- patient preference data
- risk management
- medical device approval
- clinical trials
- safety thresholds
Keywords
- patient preference
- risk management
- FDA approval
- clinical trials
- adverse events
- medical devices
- safety thresholds
Mentioned in this episode
Organizations: FDA
More episodes of Let's Talk Risk! with Dr. Naveen Agarwal
- LTR 158: Three Questions To Keep Risk Connected to Decisions · June 12, 2026 · 28 min
- LTR 157: Why Risk Doesn't Get Heard and How to Change That · May 29, 2026 · 27 min
- LTR 156: Using AI as a Thinking Partner in Product Development Without Losing Control · May 22, 2026 · 27 min
- LTR 155: Leverage VIP to Move from Compliance to Capability · May 15, 2026 · 26 min
- LTR 154: From Procedures to Judgment - Leading Through QMSR Inspections · May 8, 2026 · 39 min
- LTR 153: Sherita Black on Building a Practical Policy for Risk Acceptability · May 1, 2026 · 29 min
Explore listener stats, chart rankings, contacts and more on the Let's Talk Risk! with Dr. Naveen Agarwal podcast page.